InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Browse the detailed record of transactions filed by Sauer Paul, SVP, Développement des Processus. Insider active across 1 companies, notably Vaxcyte, Inc.. Aggregated, 11 disclosures have been published. Total volume traded: €970k. The latest transaction was disclosed on 23 May 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations11 total
€73,6473,000 shares@ €24.54910.0012% mcap7.6% of flow
Common Stock
SEC:0001209191-22-031865:0·
€69,2193,000 shares@ €23.0730.0011% mcap7.1% of flow
Common Stock
SEC:0001209191-22-025654:0·
€68,0753,000 shares@ €22.69170.0011% mcap7.0% of flow
Common Stock
SEC:0001209191-22-020962:0·
€135,4556,000 shares@ €22.57580.0022% mcap14.0% of flow
Common Stock
SEC:0001209191-22-018522:0·
010,000 shares0
Common Stock
SEC:0001209191-22-016522:0·
€132,5706,000 shares@ €22.0950.0022% mcap42.5% of flow
Common Stock
SEC:0001209191-21-071604·
€132,5706,000 shares@ €22.0950.0022% mcap13.7% of flow
Common Stock
SEC:0001209191-21-071604:0·
€64,8983,000 shares@ €21.63250.0011% mcap20.8% of flow
Common Stock
SEC:0001209191-21-062762·
€64,8983,000 shares@ €21.63250.0011% mcap6.7% of flow
Common Stock
SEC:0001209191-21-062762:0·
€114,4145,307 shares@ €21.55920.0019% mcap36.7% of flow
Common Stock
SEC:0001209191-21-057651·
€114,4145,307 shares@ €21.55920.0019% mcap11.8% of flow
Common Stock
SEC:0001209191-21-057651:0·
11 of 11 declarations
About Sauer Paul
Paul Sauer is the SVP Process Development and Manufacturing at Vaxcyte, Inc. He oversees process development and manufacturing initiatives, ensuring efficiency and quality of products. His role is essential in supporting Vaxcyte's growth.
